Invention Grant
- Patent Title: Methods of treating cancer using compounds containing a vascular disrupting agent
-
Application No.: US15297649Application Date: 2016-10-19
-
Publication No.: US09937267B2Publication Date: 2018-04-10
- Inventor: Robert Andrew Falconer , Jason Gill , Jennifer Xavier , Paul Loadman , Michael Bibby , Laurence Patterson
- Applicant: Incanthera Ltd
- Applicant Address: GB Manchester
- Assignee: Incanthera Ltd
- Current Assignee: Incanthera Ltd
- Current Assignee Address: GB Manchester
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Muriel Liberto, Esq.
- Priority: GB0819287.4 20081022
- Main IPC: A61K47/48
- IPC: A61K47/48 ; C07K7/06 ; A61K38/08 ; A61P35/00 ; A61K31/165 ; A61K31/135
Abstract:
The present invention relates to prodrugs of vascular disrupting agents comprising a vascular disrupting agent (VDA) associated with a MMP proteolytic cleavage site and to the use of such prodrugs in the targeted treatment of cancer.
Public/Granted literature
- US20170266307A1 Methods Of Treating Cancer Using Compounds Containing A Vascular Disrupting Agent Public/Granted day:2017-09-21
Information query
